The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Diclofenac 75 mg/Misoprostol 200 micrograms modified release tablets

75 mg/200 microgram(s) Modified-release tablet

Morningside Healthcare LtdPA1333/014/002

Main Information

Trade NameDiclofenac 75 mg/Misoprostol 200 micrograms modified release tablets
Active SubstancesDiclofenac sodium
Strength75 mg/200 microgram(s)
Dosage FormModified-release tablet
Licence HolderMorningside Healthcare Ltd
Licence NumberPA1333/014/002

Group Information

ATC CodeM01BA Antiinflammatory/antirheumatic agents in combination with corticosteroids
M01BA55 Acetic acid derivatives and related substances


Withdrawn Date11/03/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0058-113-021
Interchangeable List DocumentPDF of Interchangeable List
« Back